University of Alabama at Birmingham
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
Inclusion Criteria: * Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty Exclusion Criteria: * Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.
one group of subjects will receive oral tranexamic acid and the other will receive oral placebo
one group of randomized subjects will receive placebo and the other will receive oral tranexamic acid
Verify or correct the compensation shown for this listing.